Compounds acting on the central nervous system. IV. 4-substituted 2,3-polymethylenequinolines.
D000613:Aminobutyrates / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D002415:Cats; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D002625:Chemistry, Organic; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004336:Drug Antagonism; D006168:Guinea Pigs; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009552:Nikethamide / Q000494:pharmacology; D055601:Organic Chemistry Phenomena; D010424:Pentobarbital / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012137:Respiratory System / Q000187:drug effects; D013874:Thiopental / Q000494:pharmacology
D000613:Aminobutyrates; D000700:Analgesics; D000779:Anesthetics, Local; D000697:Central Nervous System Stimulants; D002800:Cholinesterase Inhibitors; D011804:Quinolines; D009552:Nikethamide; D009020:Morphine; D010424:Pentobarbital; D013874:Thiopental; D010433:Pentylenetetrazole; D010634:Phenobarbital